REQUEST A DEMO
Total
USD $0.00
Search more companies

Lantset AO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Health and Personal Care Stores | Ambulatory Health Care Services
Full name: Lantset AO Profile Updated: January 09, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

JSC Lancet is a pharmaceutical distributor. The company provides healthcare centers throughout Russia with pharmaceuticals, high-technology equipment, and devices. Lancet operates in the public hospital market and has a strong presence in the supply of anticoagulants and preparations for anaesthesiology and resuscitation. Additionally, Lancet offers equipment for rehabilitating patients suffering from acute coronary syndrome and "Lancet-Cardiomonitoring" software for monitoring all stages of diagnosis and treatment of patients. The company collaborates with manufacturers and scientific societies to support programs aimed at developing the Russian healthcare system. Lancet is among the top 10 largest Russian distributors on the gross sales market, with a 53% increase in sales compared to the previous year.

Headquarters
Ulitsa Cherkizovskaya B., Dom 24A, Stroenie 1, Ofis 527
Moscow; Moscow; Postal Code: 107553

Contact Details: Purchase the Lantset AO report to view the information.

Website: http://lancetpharm.ru

Basic Information
Outstanding Shares:
Purchase the Lantset AO report to view the information.
Registered Capital:
Purchase the Lantset AO report to view the information.
Incorporation Date:
February 08, 2005
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lantset AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
21.68%
Total operating revenue
21.68%
Operating profit (EBIT)
10.2%
Net Profit (Loss) for the Period
1.88%
Total assets
11.29%
Total equity
-4.85%
Operating Profit Margin (ROS)
-0.9%
Net Profit Margin
-1.13%
Return on Equity (ROE)
4.44%
Quick Ratio
-0.12%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?